Tags: flibanserin | female | viagra | study

Flibanserin, 'Female Viagra,' Not All That Effective, Study Finds

Image: Flibanserin, 'Female Viagra,' Not All That Effective, Study Finds
(addyi.com)

By    |   Wednesday, 02 Mar 2016 10:42 AM

Flibanserin, which has been called the "female Viagra," may not work so well, according to a study released Monday by the journal JAMA Internal Medicine.

Flibanserin, manufactured by Valeant Pharmaceuticals' Sprout under the trade name Addyi, hit the market in October and was hailed as a treatment for female sexual dysfunction, according to Glamour. Dr. Jennifer Wider, a woman's health expert, told the magazine that there were doubts about the drug from the start.

"Female sexual dysfunction can be more complicated and harder to address, in some cases, than the mechanics of male erectile dysfunction," Wider said. "So treating women with this drug was not likely to be a cure-all."

According to the new research, 5,900 women participating in five published and three unpublished studies saw little improvement in their sex lives.

"Treatment with flibanserin, on average, resulted in one-half additional SSE (satisfying sexual event) per month while statistically and clinically significantly increasing the risk of dizziness, somnolence, nausea, and fatigue," the study's abstract states.

"Overall, the quality of the evidence was graded as very low. Before flibanserin can be recommended in guidelines and clinical practice, future studies should include women from diverse populations, particularly women with comorbidities, medication use, and surgical menopause," the study continues.

Bloomberg Business reported in November
that the drug was a flop in the marketplace as well, generating only 227 prescriptions over its first few weeks — that's compared to the 600,000 men that Glamour said received prescriptions for Viagra during its first month on the market.

"I thought there was going to be this huge onslaught," Stephanie Faubion, director of the Women's Health Clinic at the Mayo Clinic in Rochester, Minnesota, told Bloomberg at the time. "There have been a few casual inquiries, but no prescriptions yet."

© 2017 Newsmax. All rights reserved.

 
1Like our page
2Share
TheWire
Flibanserin, which has been called the "female Viagra," may not work so well, according to a study released Monday by the journal JAMA Internal Medicine.
flibanserin, female, viagra, study
294
2016-42-02
Wednesday, 02 Mar 2016 10:42 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved